KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Thermo Fisher Scientific (TMO) EBIT Margin (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of EBIT Margin readings, the most recent being 16.93% for Q1 2026.

  • On a quarterly basis, EBIT Margin rose 37.0% to 16.93% in Q1 2026 year-over-year; TTM through Mar 2026 was 17.46%, a 24.0% increase, with the full-year FY2025 number at 17.38%, up 27.0% from a year prior.
  • EBIT Margin hit 16.93% in Q1 2026 for Thermo Fisher Scientific, down from 18.46% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 23.87% in Q2 2022 to a low of 14.59% in Q2 2023.
  • Median EBIT Margin over the past 5 years was 17.03% (2023), compared with a mean of 17.24%.
  • Biggest five-year swings in EBIT Margin: tumbled -928bps in 2023 and later soared 250bps in 2024.
  • Thermo Fisher Scientific's EBIT Margin stood at 16.25% in 2022, then increased by 5bps to 17.03% in 2023, then grew by 4bps to 17.69% in 2024, then rose by 4bps to 18.46% in 2025, then dropped by -8bps to 16.93% in 2026.
  • The last three reported values for EBIT Margin were 16.93% (Q1 2026), 18.46% (Q4 2025), and 17.45% (Q3 2025) per Business Quant data.